Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
1.600
+0.070 (4.58%)
Dec 3, 2024, 11:52 AM EST - Market open
Kairos Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 3, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 21 | - | - | - |
| Enterprise Value | 17 | - | - | - |
| Debt / Equity Ratio | 0.04 | -0.31 | -0.50 | -0.34 |
| Debt / FCF Ratio | - | 7.93 | - | - |
| Quick Ratio | 1.92 | 0.04 | 0.27 | 0.04 |
| Current Ratio | 2.84 | 0.04 | 0.27 | 0.04 |
| Return on Assets (ROA) | -41.71% | -107.07% | -39.41% | - |
| Buyback Yield / Dilution | -2.97% | -1.42% | -11.86% | - |
| Total Shareholder Return | -2.97% | -1.42% | -11.86% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.